Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A10888 | Pages: NA | Charts: NA | Tables: NA |
Robotic surgery, or robot-assisted surgery, allows doctors to perform many types of complex procedures with more precision, flexibility and control than is possible with conventional techniques. Robotic surgery is usually associated with minimally invasive surgery procedures performed through tiny incisions. It is also sometimes used in certain traditional open surgical procedures. The microsurgery field is the surgical field that joins magnification with the developed diploscopes, the precision tools that are specialized and different working procedures. These methods are fundamentally utilized to anastomose the small vessels of blood (veins and arteries) and to the coapt nerves. Micro neural and micro vascular coaptation take into consideration complex fix of the human tissue after cancer, congenital deficiencies and trauma. Microsurgery robots are stealing the spotlight owing minimally invasive nature, high precision and better patient outcome.
Covid-19 Scenario analysis:
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people who fall sick with COVID-19 will experience mild to moderate symptoms and recover without special treatment. The change during the COVID-19 pandemic has overhauled our dependence on pattern setting developments, for instance, expanded reality, computer generated reality, and the Healthcare web of things. The unfulfilled cash related targets are persuading the relationship to grasp robotization and forefront advancements to stay ahead in the market competition. Associations are utilizing this open entryway by recognizing step by step operational needs and showing robotization in it to make an automated structure as far as might be feasible. The low cross contamination because of sterility maintained by Robotic surgery will gain preference in the post pandemic season and the risk of surgeons getting infected by corona will also be eliminated by robotic surgery hence the microsurgery robot market will experience growth.
High prevalence of cancer is projected to increase the application of microsurgery robot in oncology treatments. Brain, colorectal, prostate, and other types of cancer treatments involve the use of robotic surgery. Lower number of post-operative complications and shorter recovery time are some of the advantages of using robot surgery in cancer treatments. Besides hospitals and clinics, ambulatory surgical centres are foretold to augment the demand in the global microsurgery robot market. Increasing adoption of surgical robots could be a primary factor stoking the demand for microsurgery robot in ambulatory surgical centres.
High success rate:
Microsurgery robot helps with minimum scarring and reduced hospital stays. Furthermore, rising prevalence of chronic diseases is expected to cause a surge in the demand for microsurgery robot. The need to treat chronic conditions increases the requirement of surgical procedures. There are a number of benefits associated with robotic-assisted surgery. The growth is attributable to growing burden of chronic diseases on healthcare industry. Multi-specialty hospitals offer advanced therapeutic solutions to patients, thereby improving patient outcomes. Affordability of hospitals to buy technologically advanced robotic systems and increasing adoption of minimally invasive surgical procedures will increase demand for microsurgery robot in assessment period.
Robotic-assisted microsurgery can be utilized for either intracorporal or extracorporeal surgical procedures. Three-dimensional high-definition magnification, a stable ergonomic platform, elimination of physiologic tremor, and motion scaling make the robotic platform attractive for micro surgeons for complex procedures. Additionally, robotic assistance enables the micro surgeon to take microsurgery to challenging intracorporal locations in a minimally invasive manner. Recent adjunctive technological developments offer the robotic platform enhanced optical magnification, improved intraoperative imaging, and more precise ablation techniques for microsurgical procedures. The advent of the operative microscope allowed surgeons to perform ultrafine surgical procedures in reconstructive plastic surgery and neurosurgery. In open surgery, the use of minimally invasive techniques such as laparoscopy and robotic-assisted laparoscopy has also evolved. The advantages of the robotic surgical system in laparoscopy have clearly led to its gaining momentum for these types of procedures. As the robotic platform has become more widespread, micro surgeons have also explored its potential use in microsurgery.
Microsurgical procedures occasionally require magnification in the 20 to 25× range to clearly view ultrafine anatomical structures. However, one of the caveats of the da Vinci robotic 3D HD camera is its limited 10 to 15× digital magnification. The digital camera of the robotic platform may reveal pixilation at the maximum magnification levels decreasing image resolution at this high magnification. This will help boost the market.
Robotic surgery involves risk, some of which may be similar to those of conventional open surgery, such as a small risk of infection and other complications. Also, the high cost of surgery will also restrain the market.
The evolution of microsurgeries is first robot is MUSA which is the world’s first clinically available CE-certified surgical robot for microsurgery. It is developed by a team of engineers and micro surgeons, creating a solution that is compatible with current operating techniques, instruments and other OR-equipment. The flow and infrastructure of the OR remain unchanged. MUSA scales down motion seamlessly, and filters out tremor to help you perform at the micro-scale of life.
Key benefits of the report:
Questions answered in the Microsurgery robot Market research report:
Key Market Segments
Key Market Players